Suzanne Rosenberg's proposal funded!

Thu, 04 Dec 2014 14:44:03 -0500

Suzanne Rosenberg’s “Recombinant Bi-specific Cytotoxic Lymphocyte-activating Polypeptides for Tumor Immunotherapy” project submitted to the UMBC Techology Catalyst Fund is funded in full.